HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 1,717-1,728 of 1,811
Drug study icon
CompletedNCT01183234

SPD544 High Strength Bioequivalence Study

Official study title

Phase 1,Randomized,Open-Label,Two Period Single Dose Crossover Bioequivalence Study of Two Capsule Strengths of SPD544 In Healthy Volunteers.

This study has finished and is no longer accepting participants.

In London
ADHDMedication studyAges 18–55
Countries
United Kingdom
Sponsor
Shire
Drug study icon
CompletedNCT03769064

Study for Naltrexone on the Abuse Potential of Methylphenidate

Official study title

Phase 1, Single-dose, Double-blind, Rand., Placebo- and Active-controlled, 4-period, 4-sequence Crossover, Proof-of-Concept Study to Evaluate Effect of Naltrexone on Abuse Potential of Methylphenidate in Healthy Recreational Stimulant Users

This study has finished and is no longer accepting participants.

In Overland Park
ADHDMedication studyAges 18–45
Countries
United States
Sponsor
Avekshan LLC
Other study type icon
CompletedNCT00472511

Eyes and Attention Deficit (SEAD)

Official study title

Study of Eyes and Attention Deficit (SEAD)

This study has finished and is no longer accepting participants.

Location not clearly listed
ADHDObservational studyAges 7–18
Countries
Sponsor
Ohio State University
Drug study icon
CompletedNCT01108029

Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease

Official study title

Study of Memantine to Treat Gait Disorders And Attention Deficit In Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Monocentric Trial

This study has finished and is no longer accepting participants.

In Lille
ADHDMedication studyAges 30–80
Countries
France
Sponsor
University Hospital, Lille
Drug study icon
CompletedNCT01924143

TD-9855 Mass Balance Study

Official study title

An Open-Label Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion of TD-9855 Following a Single Oral Dose Containing Approximately 100 µCi [14C]-Labeled TD-9855 (20 mg) in Healthy Subjects

This study has finished and is no longer accepting participants.

In Lincoln
ADHDMedication studyAges 18–50
Countries
United States
Sponsor
Theravance Biopharma
Device study icon
CompletedNCT04278430

Transcranial Direct Current Stimulation for Attention Deficit

Official study title

Does Transcranial Direct Current Stimulation Affect Selective Visual Attention in Children With Left-sided Infantile Hemiplegia? A Preliminary Randomized Controlled Study

This study has finished and is no longer accepting participants.

Location not clearly listed
ADHDDevice studyAges 8–15
Countries
Sponsor
Majmaah University
Drug study icon
CompletedNCT07486895

study to Demonstrate the Equivalence of Two Different Strengths of Oral Centanafadine Capsules in Healthy Subjects

Official study title

An Open-label, Randomized, Crossover Trial in Healthy Subjects to Assess Dose Strength Equivalence Among 164.4 and 328.8 mg Strengths of Oral Centanafadine QD XR Capsules

This study has finished and is no longer accepting participants.

In Lenexa
ADHDMedication studyAges 18–55
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT01993849

Use of N-Acetylcysteine (NAC) in Fingernail Biting

Official study title

A Randomized Placebo-controlled Trial of N-Acetylcysteine in Onychophagia

This study has finished and is no longer accepting participants.

In Charleston
ADHDMedication studyAges 18–30
Countries
United States
Sponsor
Kevin Gray, MD

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.